ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

UCLA Hutchinson, UPa. Reportedly Winners Of Fast Neutron Awards

September 21, 1979

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989